Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Clariant AG (CLZNY) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
New Funding Round Led by Addition Follows Platform Revenue Growth of Over 700% MINNEAPOLIS–(BUSINESS WIRE)–Branch,…
Company adds former Salesforce Executive, John Stewart, to its Board ROCKVILLE, Md.–(BUSINESS WIRE)–Autosled, the modern…
As Teradata’s exclusive licensee of BitBox™ automated drill bit inspection technology, Wellbore Matters, a Texas…
6G program director joins a diverse group of experts to advise FCC on technology policies…
The nation’s first and only land, sea, and air robotics innovation lab is launching during…
IRVINE, Calif.–(BUSINESS WIRE)–#mortgage—Advantage Systems, a provider of accounting and financial management tools for the mortgage…
Findings Reveal IDP Adoption the Most Significant Development in Mortgage Industry; Addresses Trillion-dollar Industry’s Emergent…
COLUMBIA, Md.–(BUSINESS WIRE)–Welldoc®, a digital health leader revolutionizing chronic care, today announced that it was…
Houston, Texas, USA, March 09, 2022 (GLOBE NEWSWIRE) — Invectys, Inc. of Houston, Texas, a…
Roth Capital Partners has initiated research coverage on 22nd Century Group. BUFFALO, N.Y., March 09,…
ROCHESTER, N.Y., March 09, 2022 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology…
MIAMI, March 09, 2022 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative…
Preclinical data will be presented in a late-breaking abstract session WESTPORT, Conn., March 09, 2022…
LAVAL, Quebec, March 09, 2022 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”)…
$32.2 Million Fourth Quarter Net Product Sales, a 7% Increase from Fourth Quarter 2020 and $109.4…
Company to Present Adhesions Prevention Data on Wednesday, March 16, 2022, at 8:30 a.m. ET…